Pharmacokinetics and Tissue Distribution of Recombinant Human Alpha A, D, A/D(Bgl), and I Interferons and Mouse Alpha-Interferon in Mice
Citations Over TimeTop 23% of 1986 papers
Abstract
The pharmacokinetics and tissue distribution in mice of several recombinant human alpha-interferons [rHuIFN-alpha A, D, I, and A/D(Bgl)] as well as natural mouse alpha-interferon (MuIFN-alpha) were assessed following single intravenous injections. The serum profiles of rHuIFN-alpha A, rHuIFN-alpha D, rHuIFN-alpha A/D(Bgl), and MuIFN-alpha were similar, whereas those following rHuIFN-alpha I showed a much longer terminal elimination phase. Differences in elimination half-life, volume of distribution, and total body clearance between these IFNs were observed. There was appreciable uptake of IFN in the kidney: the amount of each interferon per gram of tissue in the kidney ranges from 1 to 9 times the amount found in the serum. The greatest uptake appeared with rHuIFN-alpha D, followed by rHuIFN-alpha A, rHuIFN-alpha A/D(Bgl), and MuIFN-alpha. The only exception was rHuIFN-alpha I which showed no uptake into the kidney.
Related Papers
- → Pharmacokinetics of 5-fluorouracil in colorectal cancer patients receiving interferon(1993)18 cited
- → Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2 b(1988)14 cited
- → Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-α-2b(1999)8 cited
- → A Pharmacokinetic Study of 5-FU/Leucovorin and Alpha-Interferon in Advanced Cancer(2000)2 cited
- Therapy of chronic non-A, non-B hepatitis with alpha interferon. A comparison between natural and recombinant alpha interferon.(1993)